22nd week of 2017 patent applcation highlights part 17 |
Patent application number | Title | Published |
20170152289 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE - The invention relates to a process for solution-phase synthesis of D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide, an active ingredient used for both common and rare diseases including a mitochondrial targeted therapy for ischemia reperfusion injury. | 2017-06-01 |
20170152290 | BETA HAIRPIN PEPTIDES HAVING ANTIVIRAL PROPERTIES AGAINST DENGUE VIRUS - The present invention discloses structurally constrained synthetic peptides that have been optimized for the formation of a beta hairpin structure. Said peptides are able to inhibit or attenuate Dengue virus (DENV) infections. The invention also discloses pharmaceutical compositions containing these synthetic peptides, which are useful for the prevention and/or treatment of DENV-caused infections. Likewise, the invention disclosed a method for treating infections caused by this virus. | 2017-06-01 |
20170152291 | N- (HYDROPHOBE-SUBSTITUTED) VANCOSAMINYL [PSI-[C(=NH) NH] TPG4] VANCOMYCIN AND [PSI-[CH2NH]TPG4] VANCOMYCIN - The total synthesis and evaluation of key analogs of vancomycin containing single atom changes in the binding pocket are disclosed as well as their peripherally modified, N-(hydrophobe-substituted) derivatives exemplified by a N-4-(4′-chlorob-phenyl)-methyl derivative and their pharmaceutically acceptable salts are disclosed. Their evaluation indicates the combined pocket and peripherally modified analogs exhibit a remarkable spectrum of antimicrobial activity and truly impressive potencies against both vancomycin-sensitive and -resistant bacteria, and likely benefit from two independent and synergistic mechanisms of action. A pharmaceutical composition containing a contemplated compound or its pharmaceutically acceptable salt is disclosed, as is a method of treating a bacterial infection in a mammal by administering an antibacterial amount of a contemplated compound or its salt as above to an infected mammal in need of treatment. | 2017-06-01 |
20170152292 | RESPIRATORY SYNCYTIAL VIRUS (RSV) REPLICATION INHIBITORS - The invention provides polypeptides interacting with the binding of the RSV phosphoprotein P with the RSV nucleoprotein N and methods of using such polypeptides in the treatment and/or prevention of RSV infection. | 2017-06-01 |
20170152293 | RECOMBINANT CYTOTOXIN AND USE THEREOF - A recombinant cytotoxin is provided. The recombinant cytotoxin of the present invention comprises a cytotoxin, a cell penetrating peptide (CPP), and Asp-Glu-Val-Asp (DEVD) sequence inserted in the cytotoxin. The recombinant cytotoxin can induce a targeting cell into the apoptotic pathway and be cleaved by the enzyme generated from apoptotic pathway. The present invention also provides a method for treating cancer, comprising administrating the recombinant cytotoxin to a subject. | 2017-06-01 |
20170152294 | METHOD FOR EXTRACTING SOLUBLE PROTEINS FROM MICROALGAL BIOMASS - Method for preparing a protein isolate of the biomass of microalgae of the genus | 2017-06-01 |
20170152295 | CALCIUM REPORTER GENE - As a calcium indicator protein having an excellent fluorescent characteristic and calcium reactivity, there is provided DNA in which one of a nucleotide sequence derivative of a calmodulin-binding sequence (ckkap sequence) of calcium/calmodulin-dependent protein kinase kinase and a nucleotide sequence encoding a calcium-binding sequence (CaM sequence) of calmodulin is linked to a 5′ end of a nucleotide sequence encoding a fluorescent protein, and the other nucleotide sequence is linked to a 3′ end of the nucleotide sequence encoding the fluorescent protein. The calcium indicator protein encoded by this DNA, which based on the derivative of the ckkap sequence as a binding domain for the calcium-bound CaM sequence, exhibits a fluorescent characteristic and calcium reactivity superior to those of conventional calcium indicator proteins. | 2017-06-01 |
20170152296 | COMPOSITIONS FOR THE TREATMENT OF WOUNDS - Recombinant polypeptides and compositions as described herein and are useful in methods to promote epidermal tissue regeneration and/or to promote wound healing in a variety of tissues subject in need thereof. The method comprises administering to a tissue or wound in need thereof an effective amount of a recombinant polypeptide operatively linked to a carrier protein or a composition containing the recombinant polypeptide linked to a carrier protein. | 2017-06-01 |
20170152297 | DRUG REGULATED TRANSGENE EXPRESSION - The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively transferring CD8+ central memory T cells or combinations of central memory T cells with CD4+ T cells that are genetically modified to express a chimeric receptor under the control of an inducible promoter. In some alternatives the genetically modified host cell comprises a nucleic acid comprising a polynucleotide coding for a chimeric antigen receptor comprising a ligand binding domain, a polynucleotide comprising a spacer region, a polynucleotide comprising a transmembrane domain, and a polynucleotide comprising an intracellular signaling domain under the control of a drug inducible promoter. Controlling the expression of the chimeric receptor provides for the ability to turn expression on and off depending on the status of the patient. Pharmaceutical formulations produced by the method, and methods of using the same, are also described. | 2017-06-01 |
20170152298 | PROCESS FOR THE PURIFICATION OF TNFR:FC FUSION PROTEIN - The present invention relates to the purification of TNFR:Fc fusion protein. More specifically related to process of purification of TNFR:Fc fusion protein wherein the HCP is reduced. The present invention is directed to the use of mixed-mode chromatography and/or affinity chromatography to produce TNFR:Fc fusion protein which is substantially free of at least one of the protein degrading enzyme present in HCP. | 2017-06-01 |
20170152299 | HUMAN FGFR2B EXTRACELLULAR DOMAIN AND NUCLEIC ACID FOR CODING SAME - Provided are wild-type, S252W mutant-type, and P253R mutant-type FGFR2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an Fc segment. Also provided are applications of the proteins and a composition comprising the proteins in treating eczema, acne, psoriasis, skin allergy, seborrheic dermatitis, or seborrheic alopecia. | 2017-06-01 |
20170152300 | MODIFIED VON WILLEBRAND FACTOR - The present invention provides a modified polypeptide which binds Factor VIII. The modified polypeptide comprises a sequence as shown in SEQ ID NO:3 in which the sequence comprises at least a modification at position 1 or 3 such that the modified polypeptide binds to Factor VIII with an off rate at least 5 fold lower than a reference polypeptide comprising an unmodified SEQ ID NO:3. | 2017-06-01 |
20170152301 | METHODS OF MAKING HIGH-STRENGTH NDGA POLYMERIZED COLLAGEN FIBERS AND RELATED COLLAGEN-PREP METHODS, MEDICAL DEVICES AND CONSTRUCTS - The disclosure describes methods of making high-strength NDGA collagen and associated methods of preparing collagen preparatory material and medical bioprostheses. | 2017-06-01 |
20170152302 | ANTI-APOPTOTIC FUSION PROTEINS FOR REDUCING MYOCARDIAL INFARCTION SIZE - The present invention relates to a fusion protein comprising a protein transduction domain capable of introducing the fusion protein into a mammalian cell and an anti-apoptotic protein comprising the amino acid of the sequence of SEQ ID NO:1 or an anti-apoptotically active variant or fragment thereof. The invention also relates to a pharmaceutical composition comprising such a fusion protein, in particular for blocking apoptosis in a patient in need thereof. The invention also provides a polynucleotide encoding such a fusion protein, an expression vector comprising the polynucleotide and a host cell comprising the expression vector. In a further aspect, the invention relates to the use of any of theses materials for the preparation of a medicament for blocking apoptosis in a patient in need thereof. | 2017-06-01 |
20170152303 | METHODS OF CURING HBV INFECTION AND PROVIDING COMPLETE PROTECTION AGAINST HBV INFECTION - Disclosed are the methods of curing HBV infection and providing complete protection against HBV infection in a simplified HBV immunization schedule. The mechanistic basis for curing HBV infection is founded on the understanding that hepatitis B virus infection is established and prolonged by new rounds of infection with continuously produced viruses, which are not fully neutralized because of insufficient endogenous neutralizing antibodies. The methods of curing HBV infection including chronic HBV infection are aimed to block new rounds of HBV infection. The guidelines for establishing treatment regimens for curing HBV infection, include production or administration of sufficient level of HBV neutralizing antibodies in treated patients. Among the many different possibilities contemplated, the sufficient level of HBV neutralizing antibodies is expressed and maintained by the single injection of the HBV therapeutics that comprises non-replicating viruses or vectors encoding HBV neutralizing antibodies or by multi-injection of exogenous HBV neutralizing antibodies. | 2017-06-01 |
20170152304 | TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY - Described is an anti-HSV antibody or an antigen-binding fragment thereof for use in treating an acute infection of mucosal or epidermal tissue in a subject caused by HSV-1 or HSV-2 selected from the group consisting of Herpes simplex labialis, Herpes simplex genitalis, chronic or disseminated cutaneous herpes simplex infection, Herpes gladiatorum and Eczema herpeticum, wherein said antibody is to be topically administered as well as to a pharmaceutical composition comprising an effective amount of said antibody or antigen-binding fragment thereof and at least one pharmaceutically acceptable excipient. | 2017-06-01 |
20170152305 | EXPRESSION OF A SINGLE CHAIN ANTIBODY AGAINST SALMONELLA IN LACTOBACILLUS - The present disclosure relates to camel id antibodies that inhibit growth, and colonization of | 2017-06-01 |
20170152306 | SINGLE CHAIN VARIABLE FRAGMENT (SCFV) ELONGATION MUTANTS - The present invention relates to the provision of single chain variable fragment (scFv) elongation mutants. In addition, the present invention relates to a pharmaceutical composition comprising said scFv elongation mutants, as well as a nucleotide sequence encoding said scFv elongation mutants, a vector comprising said nucleotide sequence or a host cell expressing said nucleotide sequence. Particular embodiments relate to elongation mutants of the scFv-h3D6 which is derived from monoclonal antibody mAb-h3D6 (bapineuzumab). It is further disclosed a method of prevention or treatment of a patient in risk of suffering, or already diagnosted as suffering, Alzheimer disease that comprises the administration to said patient of an effective amount of the scFv elongation mutants of scFv-h3D6. | 2017-06-01 |
20170152307 | ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT SPECIFICALLY BIND TO MICROTUBULE-ASSOCIATED PROTEIN TAU - The disclosure relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The disclosure also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies. | 2017-06-01 |
20170152308 | TDP-43 Specific Binding Molecules - Provided are novel TDP-43-specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these TDP-43 specific binding molecules. Assays, kits, and solid supports related to TDP-43-specific binding molecules, including polypeptides such as, human antibodies are also disclosed. The TDP-43-specific binding molecule, antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for TDP-43 targeted immunotherapy and diagnosis, respectively. | 2017-06-01 |
20170152309 | ANTI-COMPLEMENT FACTOR C1Q FAB FRAGMENTS AND USES THEREOF - The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same. | 2017-06-01 |
20170152310 | ANTIBODIES RECOGNIZING ALPHA-SYNUCLEIN - The invention provides monoclonal antibody 5C1 and related antibodies. The 5C1 antibody binds to an epitope within residues 118-126 of α-synuclein. The antibodies of the invention are useful, for example, for treating and/or diagnosing disorders associated with α-synuclein, particularly accumulation of α-synuclein deposits. Such disorders include Lewy body diseases, such as Parkinson's disease, Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy (MSA). | 2017-06-01 |
20170152311 | M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF - M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease. | 2017-06-01 |
20170152312 | ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM) - The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods. | 2017-06-01 |
20170152313 | LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE - The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same. | 2017-06-01 |
20170152314 | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-DESMOGLEIN-3 ANTIBODIES - Methods that involve detection of a DSG3 protein for diagnosing cancer are disclosed. In lung cancer, the expression of DSG3 was found to be enhanced at very high frequency at the gene level and protein level. Methods of the present invention can be carried out using an antibody that recognizes a DSG3 protein. Pharmaceutical compositions, cell growth inhibitors, and anticancer agents containing a DSG3-binding antibody as an active ingredient are also disclosed. Methods of inducing cell damage in DSG3-expressing cells and methods of suppressing proliferation of DSG3-expressing cells by contacting the DSG3-expressing cells with DSG3-binding antibodies are also disclosed. | 2017-06-01 |
20170152315 | Anti-CD19 Antibodies - The present invention provides humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases. In more particular embodiments, the humanized anti-CD19 antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels. In a particularly preferred embodiment, the substitutions comprise a Ser9lPhe substitution in the hA19 VH sequence. | 2017-06-01 |
20170152316 | FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS - A targeted T-cell engaging agent for treating a condition characterized by the presence of unwanted cells includes (a) a targeting moiety that is capable of targeting the unwanted cells; (b) a first T-cell engaging domain capable of T-cell engaging activity when binding a second T-cell engaging domain, wherein the second T-cell engaging domain is not part of the agent; (c) at least one inert binding partner capable of binding to the first T-cell engaging domain such that the first T-cell engaging domain does not bind to the second T-cell engaging domain unless the inert binding partner is removed; and (d) at least one cleavage site separating the first T-cell engaging domain and the inert binding partner, wherein the cleavage site is: (i) cleaved by an enzyme expressed by the unwanted cells; (ii) cleaved through a pH-sensitive cleavage reaction inside the unwanted cell; (iii) cleaved by a complement-dependent cleavage reaction; or (iv) cleaved by a protease that is colocalized to the unwanted cell by a targeting moiety that is the same or different from the targeting moiety in the agent. | 2017-06-01 |
20170152317 | GALECTIN IMMUNOTHERAPY - A method of modulating immunity in a mammal is provided by modulating Galectin-9 activity in the mammal. Promoting or enhancing immunity may be effected by activating or stimulating Galectin-9 activity in the mammal, such as by administering a Galectin-9 agonist to the mammal. The agonist may be multimeric, soluble PD-L2 or an agonist antibody that binds Galectin-9. Suppressing or preventing immunity may be achieved by inhibiting or blocking Galectin-9 activity in the mammal, such as by administering an antagonist antibody or antibody fragment that binds Galectin-9 or that prevents or inhibits PD-L2 multimerisation and/or binding to Galectin-9. The aforementioned methods may be suitable for preventing or treating a disease, disorder or condition responsive to modulation of Galectin-9 activity. Also provided is a method of designing, screening, engineering or otherwise producing a Galectin-9 agonist, inhibitor or antagonist that may be useful for modulating immunity by modulating Galectin-9 activity. | 2017-06-01 |
20170152318 | METHODS AND COMPOSITIONS FOR MODULATION OF BLOOD-NEURAL BARRIER - Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic cerebrovascular and related diseases in combination with antagonism of the PDGF signaling pathway. The inventive method and composition is particularly suitable for conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist. | 2017-06-01 |
20170152319 | METHODS RELATED TO BIOLOGICS - The present invention relates to the characterization and production of biosimilars. | 2017-06-01 |
20170152320 | METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R) - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided. Such methods include, but are not limited to, methods of treating rheumatoid arthritis. | 2017-06-01 |
20170152321 | IL3Ralpha ANTIBODY CONJUGATES AND USES THEREOF - The present invention provides antibodies that bind to the IL-3 receptor alpha subunit alpha (Il3Rα) chain, and compositions comprising such antibodies. The present invention provides methods for inhibiting or reducing an IL3Rα-expressing cell population, the methods comprising contacting a population of IL3Rα-expressing cells (e.g., cancer cells and/or cancer stem cells) with an antibody that binds to IL3Rα. The present invention also provides antibody conjugates comprising an antibody that binds to an IL3Rα chain linked to a cytotoxic agent or anticellular agent and compositions comprising such conjugates. The present invention also provides methods for preventing, treating and/or managing a disorder associated with IL3Rα-expressing cells (e.g., a hematological cancer), the methods comprising administering to a subject in need thereof an antibody that binds to IL3Rα. | 2017-06-01 |
20170152322 | PAN-HER ANTIBODY COMPOSITION - The present invention is directed to improved therapeutics against receptors within the EGFR/ErbB/HER family that more broadly interfere with multiple members of the HER family (pan-HER inhibition). More particularly, the invention is directed to the use of antibody compositions for human cancer therapy. In vitro studies have shown that the antibody compositions of the invention targeting multiple HER family receptors are superior to antibody compositions targeting only one HER family receptor. | 2017-06-01 |
20170152323 | Anti-inflammatory molecules with tissue-targeting functions - The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed. | 2017-06-01 |
20170152324 | ANTIGEN BINDING FORMATS FOR USE IN THERAPEUTIC TREATMENTS OR DIAGNOSTIC ASSAYS - The present invention relates to antigen binding formats for use in therapeutic treatments or diagnostic assays. The present invention relates to an antigen-binding format consisting of:—a first fusion protein wherein the CH1 constant domain of an antibody is fused i) by its N-terminal end to the C-terminal end of a variable domain of an antibody and ii) by its C-terminal end to the N-terminal end of a variable domain of an antibody and,—a second fusion protein wherein the CL constant domain of an antibody is fused by its N-terminal end to the C-terminal end of a variable domain of an antibody. | 2017-06-01 |
20170152325 | METHOD FOR ISOLATING ABS GRAFT COPOLYMERS - A process for preparing an ABS graft copolymer, which comprises a step for isolating the graft copolymer B present in an aqueous dispersion by means of a precipitant which is an aqueous solution of a mixture of MgSO | 2017-06-01 |
20170152326 | Processes For The Removal Of Rubber From TKS Plant Matter - Provided herein are organic solvent-based processes for the removal of rubber from non- | 2017-06-01 |
20170152327 | UNIFIED COOLING FOR MULTIPLE POLYOLEFIN POLYMERIZATION REACTORS - A system and method for a polyolefin reactor temperature control system having a first reactor temperature control path, a second reactor temperature control path, and a shared temperature control path. The shared temperature control path is configured to combine and process coolant return streams, and to provide coolant supply for the first reactor temperature control path and the second reactor temperature control path. | 2017-06-01 |
20170152328 | UNIFIED COOLING FOR MULTIPLE POLYOLEFIN POLYMERIZATION REACTORS - A system and method for startup of a polyolefin reactor temperature control system having a first reactor temperature control path, a second reactor temperature control path, and a shared temperature control path. In some embodiments, during startup the second reactor temperature control path is configured to allow the temperature of a second reactor to rise due to the heat of the exothermic polymerization reaction occurring within reactor until reaching a predetermined setpoint temperature. In other embodiments, during startup a first reactor temperature control path is configured to include a heat exchanger used as a cooler, and a second reactor temperature control path is configured to include a heat exchanger used as a heater, to raise the temperature of the second reactor until reaching a predetermined setpoint temperature. | 2017-06-01 |
20170152329 | MITIGATION OF WAX LEVELS IN THE HIGH PRESSURE LOW DENSITY POLYETHYLENE PROCESS - In the high pressure polymerization of ethylene homopolymers or copolymers, conditions in the high pressure recycle system may lead to the build-up of low molecular weight oligomers and waxes. Sequentially draining knock-out pots, located downstream of a high pressure separator, at regular intervals can reduce the build-up of low molecular weight oligomers and waxes during the high pressure polymerization of alpha olefins. | 2017-06-01 |
20170152330 | Process of Preparation of Drag Reducing Polymers and Usage Thereof - The present invention relates to a process for preparing ultra-high molecular weight polyalphaolefin. The process consists of polymerizing alphaolefin monomers using the catalyst system consisting of supported Ziegler-Natta catalyst without internal donor in presence of co-catalyst based on alkyl aluminums. The resulting ultra-high molecular weight polyalphaolefins having intrinsic viscosity ≧10 dL/g are used as drag reducing polymers for increasing throughput in the pipelines by reducing frictional resistance in turbulent flow. | 2017-06-01 |
20170152331 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF - Provided are a curable composition including an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater, a functional polymer hardened product, a stack or a device including a functional polymer membrane, an amide compound, and a manufacturing method thereof. | 2017-06-01 |
20170152332 | FLUORINATED ELASTOMER, FLUORINATED ELASTOMER COMPOSITION, AND FLUORINATED ELASTOMER CROSSLINKED ARTICLE - To provide a fluorinated elastomer from which it is possible to produce a crosslinked article excellent in cold resistance and excellent in mechanical strength; a fluorinated elastomer composition containing said elastomer; and a fluorinated elastomer crosslinked article obtained by molding and crosslinking said composition. The fluorinated elastomer comprises units (A) based on vinylidene fluoride and units (B) based on a perfluorovinyl ether represented by CF | 2017-06-01 |
20170152333 | COPOLYMER COMPRISING OXAZOLINE MONOMERS AND USE THEREOF AS CROSSLINKER - The present application relates to novel copolymers and processes for the preparation thereof, where the copolymers comprise, as building blocks:
| 2017-06-01 |
20170152334 | pH-Sensitive Polymeric Compositions, Kits, and Methods - Provided herein are polymeric compositions having a relaxation time that is a function of pH. The polymeric compositions can include an anionic monomer, a cationic monomer, and a crosslinker. The crosslinker may comprise at least one of a diacrylate crosslinker and a dimethacrylate crosslinker. Also provided herein are methods of pH sensing, and methods of forming a polymeric composition. Kits of parts also are provided that include a polymeric composition. The polymeric compositions may be used to determine the pH of one or more biological tissues and/or liquids. | 2017-06-01 |
20170152335 | Biocompatible polymers and co-polymers, and uses thereof - The invention relates to highly biocompatible or biophilic un-cross-linked or cross-linked polymers comprising one or more side-chain active acrylic amino acids of formula I. The invention further concerns various highly biocompatible, cross-linked co-polymers comprising one or more monomers of formula I, and one or more other polymerizable monomers. Uses of such polymers and co-polymers for the production of contact lenses, intraocular lenses, implants, wound healing slabs, additives for food and cosmetics, conductive plastics, spinnable fibers, and the like are disclosed. | 2017-06-01 |
20170152336 | FUNCTIONALIZED POLYMER HYBRIDS - A method of synthesizing a polynucleotide composition includes attaching a compound including at least one initiator or at least one transfer agent for a reversible deactivation radical polymerization to an end of a nucleotide chain assembly immobilized upon a solid phase support during a solid phase synthesis of a polynucleotide so that the initiator or the transfer agent is attacked to the end of a nucleotide chain assembly in a manner which is stable under conditions of deprotection of the polynucleotide, and growing a polymer from the initiator of from a site of the chain transfer agent via the reversible deactivation radical polymerization to form the polynucleotide composition. | 2017-06-01 |
20170152337 | UNSATURATED POLYESTER RESIN SYSTEMS WITH LATENT THICKENING TENDENCIES - The invention relates to a two- or multi-component system having: at least one polyester component 1 which comprises: i) at least one unsaturated polyester; ii) at least one ethylenically unsaturated monomer; iii) at least one inorganic thickener (a1); and iv) at least one wetting- and dispersing agent (a2) that inhibits the thickening action of the inorganic thickener (a1); and at least one initiator component 2 which i) comprises at least one component (b1) that is able to at least partly neutralise the inhibition of the thickening action of the inorganic thickener (a1) and ii) at least one initiator that is able to trigger the polymerisation of components (i) and (ii) of the polyester component 1. The wetting- and dispersing agent (a2) is non-reactive in relation to components (i) and (ii) of the polyester component 1. The invention also relates to substrates coated with a two- or multi-component system according to the invention. The invention further relates to the use of a combination of (a1) and (a2) in formulations containing unsaturated polyesters, in order to provide said formulations with a latent thickening effect. | 2017-06-01 |
20170152338 | POLYURETHANES, ARTICLES COMPRISING THE SAME AND METHODS OF MANUFACTURE THEREOF - Disclosed herein a composition comprising a urethane of the FIG. | 2017-06-01 |
20170152339 | POLYMER BRUSH - The object of the present invention is to provide a polymer brush which forms phase-separated structure in a gas phase. The polymer brush according to the present invention comprises a substrate and a polymer layer wherein the polymer layer comprises polymer chains each of which has one end fixed on the substrate and other end free-ended, and wherein a state of phase-separation between a polymer dense part and a polymer thin part reversibly changes in the polymer layer. | 2017-06-01 |
20170152340 | PREPARATION OF POLYMERIC RESINS AND CARBON MATERIALS - The present application is directed to methods for preparation of carbon materials. The carbon materials comprise enhanced electrochemical properties and find utility in any number of electrical devices, for example, as electrode material in ultracapacitors or batteries. | 2017-06-01 |
20170152341 | POLYMERIZED ROSIN COMPOUND AND PRODUCTION METHOD THEREFOR - The polymerized rosin compound of the invention includes a rosin dimer component (A) including a bifunctional rosin dimer component (a1) represented by formula (1): ROOC—X—COOR, wherein X represents a rosin dimer residue, and R represents hydrogen, an alkyl group of 1 to 5 carbon atoms, or a benzyl group, wherein the rosin dimer component (A) contains a content of the bifunctional rosin dimer component (a1) of 80% by weight or more and the polymerized rosin compound contains a content of the rosin dimer component (A) of 80% by weight or more. The polymerized rosin compound contains a large amount of the bifunctional rosin dimer component and makes it possible to obtain linear polymer with a high molecular weight. | 2017-06-01 |
20170152342 | METHOD FOR THE CONTINUOUS PRODUCTION OF STABLE PREPOLYMERS - The invention relates to a method for the continuous production of stable prepolymers based on high-melting diisocyanates, in particular, 1,5-naphthalindiisocyanate, and to the use thereof for producing polyurethane elastomers, in particular casting elastomers. | 2017-06-01 |
20170152343 | NITROGEN-CONTAINING COMPOUNDS SUITABLE FOR USE IN THE PRODUCTION OF POLYURETHANES - The present invention relates to the use of nitrogenous compounds of formula (I) and/or corresponding quaternized and/or protonated compounds for production of polyurethanes, to compositions comprising said compounds and also to polyurethane systems, in particular polyurethane foams, obtained using said compounds. | 2017-06-01 |
20170152344 | FUNCTIONAL GRAPHENE NANOSTRUCTURE DEVICES FROM LIVING POLYMERS - The disclosure provides methods to synthesize graphene based hetero-nanostructures, the graphene based hetero-nanostructures resulting therefrom, and devices comprising the graphene based hetero-nanostructures thereof. | 2017-06-01 |
20170152345 | Process for Purifying Polycarbonate Polyols and Purifying Apparatus Therefor - The present invention relates to a purifying apparatus for polycarbonate polyols, especially for removal of cyclic alkylene carbonates, comprising an evaporation unit ( | 2017-06-01 |
20170152346 | MONOMER COMPOSITION AND CURABLE COMPOSITION CONTAINING SAME - Provided is a monomer composition that has rapid curability and can be rapidly cured, even in the presence of oxygen and/or water, to form a cured product having excellent adhesion to a wide variety of substrates. The monomer composition according to the present invention includes at least one cationically curable monomer. The at least one cationically curable monomer includes at least one of 3-allyloxyoxetane and 3-(2-ethylhexyloxy)oxetane. The at least one of 3-allyloxyoxetane and 3-(2-ethylhexyloxy)oxetane is present in a total content of 5 weight percent or more of the total weight of the monomer composition. | 2017-06-01 |
20170152347 | AMIDE DENDRIMER COMPOSITIONS - Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester. | 2017-06-01 |
20170152348 | POLYIMIDE AND POLYIMIDE FILM - A polyimide is provided. The polyimide includes a repeating unit represented by formula 1. | 2017-06-01 |
20170152349 | pH SENSITIVE QUANTUM DOTS FOR USE AS CURE INDICATORS - Disclosed is a curable sealant composition including: (i) a thiol-terminated prepolymer and/or monomers thereof, wherein the thiol-terminated prepolymer is a polythioether or a polysulfide; (ii) an “ene” crosslinker having a molecular weight of about 100 to about 5000; and (iii) a pH indicator molecule including a quantum dot functionalized with a pH-responsive ligand. Methods for determining a sufficient cure state of a composition by combining the thiol-terminated prepolymer and/or monomers thereof and the “ene” crosslinker with a pH indicator molecule, including a quantum dot functionalized with a pH-responsive ligand, and (ii) then subjecting a resultant mixture of (i) to curing conditions until the mixture changes its color are also disclosed. | 2017-06-01 |
20170152350 | Method of making a siloxane polymer composition - A siloxane polymer is made by providing a first compound having the chemical formula SiR | 2017-06-01 |
20170152351 | THERMAL INTERFACE MATERIALS INCLUDING POLYMERIC PHASE-CHANGE MATERIALS - In an example, a thermal interface material includes a polymeric phase-change material. | 2017-06-01 |
20170152352 | Manufacture method for fullerence / PEDOT:PSS mixed solution and manufacture method for compound transparent conductive film having fullerence / PEDOT:PSS - A manufacture method for fullerence/PEDOT:PSS mixed solution and a manufacture method for compound transparent conductive film having fullerence/PEDOT:PSS are provided in the present invention: making fullerence/PEDOT:PSS mixed solution to manufacture a transparent conductive film; sources of applicable materials are broad and prices thereof are cheap; the fullerence/PEDOT:PSS mixed solution can be further utilized to manufacture a compound transparent conductive film having fullerence/PEDOT:PSS on substrates or a variety of devices; the present invention discloses a manufacture method for a compound transparent conductive film having fullerence/PEDOT:PSS, and when manufacturing the compound transparent conductive film having fullerence/PEDOT:PSS via wet coating process which is with low cost and high efficiency comparing with manufacture of ITO film, and furthermore expensive PVD equipment can be waived, production cost can be reduced, manufacturing method can be simplified at the same time, production time is shorter and economic efficiency can be increased; the compound transparent conductive film having fullerence/PEDOT:PSS manufacturing in the present invention has high conductivity and high light transmittance to replace ITO films in the market. | 2017-06-01 |
20170152353 | PROCESS FOR PRODUCING WET RUBBER MASTERBATCH, WET RUBBER MASTERBATCH, AND RUBBER COMPOSITION CONTAINING WET RUBBER MASTERBATCH - A method for producing a wet rubber masterbatch uses a single-screw extruder. The single-screw extruder includes a screw, and an external cylinder in which a slit extended along the length direction of the external cylinder (the screw-shaft direction) is formed in an internal wall surface of the external cylinder, and when the width of the slit is represented by A and the clearance between a crest of the screw and the internal wall surface of the external cylinder is represented by B, the following expression (1) is satisfied: | 2017-06-01 |
20170152354 | COMPOSITE COMPONENTS ON THE BASIS OF HYDROPHOBIC POLYOLS - The present invention relates to the use of hydrophopic polyols for producing fiber composite components on the basis of a polyurethane/polyisocyanurate reaction mixture, to a method for producing composite components and to the composite components as such. The method according to the invention is particularly economical in terms of saving material and time costs and the composite components obtained are characterized by excellent visual and material properties. | 2017-06-01 |
20170152355 | Article Made by Additive Manufacturing with Continuous Fiber Reinforcements - Several examples of an article of manufacture made with an additive manufacturing machine are disclosed. A length of fiber reinforcement is provided to a nozzle. The fiber reinforcement is embedded into a stream of a base polymer material at the nozzle and deposited as a bead of composite polymer material having fiber reinforcement. The fiber reinforcement may be dry or pre-impregnated with a reinforcing polymer. The additional strength of the composite polymer material having fiber reinforcement allows for true, three-dimensional printing of articles having unsupported regions. | 2017-06-01 |
20170152356 | POLYESTER FILM INCORPORATING SILICONE FOR RELEASE OF CANNED MEAT PRODUCTS - Embodiments herein relates to a butylene terephthalate-containing multi-layer, such as a biaxially oriented polyester (BOPET) film, for lamination on metal sheets, which could be used for food containers. The BOPET film has an outer release layer, which aids in the release of food, such as a high protein food source, when food is cooked and sterilized in direct contact with the outer release layer. The BOPET film can be laminated to metals used in the manufacture of food containers with the outer release layer being exposed to allow a direct food contact between the surface of the outer release layer and food. More particularly, the invention relates to a novel outer release layer resin composition comprising an ultra high molecular weight siloxane polymer and a polyethylene trephthalate resin. Optionally, an alkali-metal phosphate and a phosphoric acid compound can be added, during polymerization the outer release layer resin composition, as a catalyst/additive package to the ingredients forming the outer release layer resin composition. | 2017-06-01 |
20170152357 | ENCAPSULATING SHEET, PRODUCTION METHOD THEREOF, OPTICAL SEMICONDUCTOR DEVICE AND ENCAPSULATED OPTICAL SEMICONDUCTOR ELEMENT - An encapsulating sheet formed from an encapsulating composition including: a silicone resin composition containing alkenyl group-containing polysiloxane, a hydrosilyl group-containing polysiloxane, and a hydrosilylation catalyst; and an inorganic filler having a refraction of 1.50 or more and 1.60 or less and an average particle size of 10 μm or more and 50 μm or less. In the average composition formula (1) and the average composition formula (2), at least one of R | 2017-06-01 |
20170152358 | FILM - A film having high heat resistance and a low total haze value and yellowness index. The film includes a fluorinated polyimide layer having a total haze value of 4 or lower, a yellowness index of 3 or lower, and a total luminous transmittance of 90% or higher. | 2017-06-01 |
20170152359 | MICROPOROUS SHEET PRODUCT AND METHODS FOR MAKING AND USING THE SAME - Microporous sheet product and methods of making and using the same. In one embodiment, the microporous sheet product is made by a process that includes melt-extruding a sheet material using an extrusion mixture that includes a thermoplastic polymer, a non-cross-linked elastomer having a molecular weight of at least 50,000 Da, and a compatibilizing agent. By way of example, the thermoplastic polymer may be a polyolefin, the non-cross-linked elastomer may be a polyisobutylene, and the compatibilizing agent may be mineral spirits. After extrusion, the sheet material may be cooled, and the sheet material may be stretched. The microporous sheet product may be used, for example, as a battery separator, as a food packaging material, as a diffusion barrier in the ultrafiltration of colloidal matter, and in disposable garments. | 2017-06-01 |
20170152360 | CYCLIC OLEFIN RESIN COMPOSITION FILM - A cyclic olefin resin composition film having excellent anti-blocking properties and toughness. The cyclic olefin resin composition film containing a cyclic olefin resin and a styrene-based elastomer; the cyclic olefin resin composition film having a first surface layer part having a thickness of from 25 to 45% of total thickness, a second surface layer part having a thickness of from 25 to 45% of the total thickness, and an internal part having thickness of from 10 to 50% of the total thickness between the first surface layer part and the second surface layer part; an average value of minor-axis dispersion diameter of the styrene-based elastomer in the first surface layer part or the second surface layer part being from 75 to 125% of an average value of minor-axis dispersion diameter of the styrene-based elastomer of the internal part. As result, it is possible to achieve excellent anti-blocking properties and toughness. | 2017-06-01 |
20170152361 | FUNCTIONAL POLYMER MEMBRANE, PRODUCTION METHOD THEREOF, AND STACK OR DEVICE PROVIDED WITH FUNCTIONAL POLYMER MEMBRANE - Provided are a functional polymer membrane including: a surface layer; and an anion exchange membrane or a cation exchange membrane, in which the surface layer contains a polymer which includes a cross-linked structure having, in a cross-linking unit, an ionic group with a charge opposite to a charge of an ionic group included in at least one of the anion exchange membrane or the cation exchange membrane; a production method thereof, and a stack or a device provided with a polymer functional membrane. | 2017-06-01 |
20170152362 | FUNCTIONAL POLYMER MEMBRANE, STACK OR DEVICE PROVIDED WITH FUNCTIONAL POLYMER MEMBRANE, AND METHOD OF PRODUCING FUNCTIONAL POLYMER MEMBRANE - Provided is a functional polymer membrane including a porous support; and a resin layer and an auxiliary layer which are supported by the porous support, in which both of the resin layer and the auxiliary layer contain an ion exchange polymer having one of an anion exchange group and a cation exchange group, a charge of the ion exchange group of the ion exchange polymer included in the resin layer is opposite to a charge of the ion exchange group of the ion exchange polymer included in the auxiliary layer, and both of the ion exchange polymers respectively included in the resin layer and the auxiliary layer are polymers having a unit obtained from an acryloyl group which may have an alkyl group at the α-position; a stack or a device provided with a functional polymer membrane; and a method of producing, a functional polymer membrane. | 2017-06-01 |
20170152363 | MOUNTING FOAM COMPOSITIONS - A mounting foam contains polyols, isocyanates, plasticizers, surfactants, a catalyst and gases. The foam contains polyols from 30% to 35% and gases from 15.5% to 17.5%, where the ratio of NCO:OH is from 3.4 to 3.9. The foam is used as an adhesive for coatings and to fill voids in structures. | 2017-06-01 |
20170152364 | COMPOSITIONS AND USES OF CIS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE - This invention relates to thermoset, thermal insulating panel, pour-in-place and spray foams having desirable and unexpectedly low thermal conductivity, and to compositions, method and systems which use and/or are used to make such foams comprising: (a) providing thermosetting foam forming component and a blowing agent for forming predominantly closed cells in the foam, wherein the blowing agent comprises: (i) cis-1,1,1,4,4,4-hexafluoro-2-butene (HFO-1336mzzm(Z)) and water, with the HFO-1336mzzm(Z) and water in the blowing agent together comprising at least about 50% by weight of the total of all components in the blowing agent and (ii) the weight ratio of HFO-1336mzzm(Z) to water in the blowing agent is from about 90:10 to less than 98:2 and (b) forming foam from said provided foamable composition. | 2017-06-01 |
20170152365 | ANTI-VIBRATION RUBBER COMPOSITION - Provided is an anti-vibration rubber composition, including: the following component (A); and the following components (B) and (C), in which a blending amount of the component (B) falls within a range of from 15 parts by weight to 60 parts by weight with respect to 100 parts by weight of the component (A), and a blending amount of the component (C) falls within a range of from 50 parts by weight to 150 parts by weight with respect thereto. Thus, the anti-vibration rubber composition is excellent in anti-vibration rubber properties, such as rubber physical properties and durability, and is excellent in flame retardancy. (A) A diene-based rubber. (B) A halogen-based flame retardant having a melting point of 150° C. or less. (C) Aluminum hydroxide having an average particle diameter of 0.75 μm or less. | 2017-06-01 |
20170152366 | Cottonseed Oil Based Liquid Color Composition and Plastics Coloring Method Using the Same - A liquid colorant for use in molding or extruding plastic products comprises pigment dispersed in cottonseed oil. | 2017-06-01 |
20170152367 | INTERNAL MOLD RELEASE AGENTS FOR POLYURETHANE MATERIALS - An internal mold release agent (IMRA) which effectively releases a cured polyurethane (PU) material from a metal, in particular steel, mold. The IMRA is a surface active agent containing phosphorus or a combination (blend or reaction product) of the agent with other chemicals. In one embodiment the agent is a phosphate ester. In one embodiment the agent is polyoxyethylene alkyl phosphate ester. A polyurethane formulation comprising the IMRA has high formulation stability, clean release, low release strength, and high product transparency. | 2017-06-01 |
20170152368 | RESIN COMPOSITION, MOLDED BODY, ELECTRONIC COMPONENT, ELECTRONIC APPARATUS, AND ELECTRONIC OFFICE APPARATUS - Provided is a resin composition including a polycarbonate and a phosphorus-containing compound, wherein a content rate of the phosphorus-containing compound in the resin composition is less than 14 percent by mass, wherein the phosphorus-containing compound includes a phosphazene derivative represented by general formula (1) below and a phosphoric acid ester, wherein a content rate of the phosphazene derivative in the resin composition is 0.1 percent by mass or greater but less than 3.0 percent by mass, and wherein a resin specific gravity (D0) of the resin composition before burned in a UL94V test and a resin specific gravity (D1) of the resin composition after burned in the UL94V test satisfy a relationship of D1/D0>0.85, | 2017-06-01 |
20170152369 | REACTIVE COMPOSITIONS CONTAINING MERCAPTO-FUNCTIONAL SILICON COMPOUND - There is provided herein a composition comprising (a) a mercapto-functional silicon compound having the general Formula (I): | 2017-06-01 |
20170152370 | Rubber Composition for Tire - A rubber composition for tires comprises a diene rubber, silica, and a silane coupling agent, and is characterized in that a function v of a shear modulus G′ of the rubber composition at 0.28% shear stress at 110° C., a CTAB specific surface area (CTAB) of the silica, a volume fraction ((φ) of the silica in the rubber composition, and a stress at 100% elongation (M | 2017-06-01 |
20170152371 | DEGRADABLE EXTRUSION RESISTANT COMPOSITIONS AND ARTICLES OF MANUFACTURE - A degradable polymer composition comprises a polyurethane comprising ester groups in a backbone of the polyurethane and carboxylic acid groups attached to the backbone of the polyurethane; and a filler comprising one or more of the following: a powder comprising particles having an average particle size of about 5 microns to about 500 microns; or a fiber having an average length of about ⅛ inch to about 5 inches. Also disclosed are articles comprising the composition. A method to degrade the article includes exposing the article to a fluid at a temperature of about 25° C. to about 300° C. | 2017-06-01 |
20170152372 | MICROSPHERES - The present invention relates to microspheres and to the use thereof, preferably as laser-absorbing additive, and to a process for the production thereof. | 2017-06-01 |
20170152373 | RUBBER COMPOSITION FOR TIRE TREAD AND TIRE MANUFACTURED BY USING THE SAME - Provided are a rubber composition for tire tread and a tire produced using this rubber composition. The rubber composition for tire tread includes 100 parts by weight of a raw material rubber, 10 to 30 parts by weight of carbon black, and 10 to 80 parts by weight of a master batch including a synthetic rubber that contains a high cis-1,4-polybutadiene rubber matrix and syndiotactic 1,2-polybutadiene dispersed in the rubber matrix. The rubber composition for tire tread can enhance the cut-chip performance and the initial grip performance of a tire produced therefrom. | 2017-06-01 |
20170152374 | Rubber Composition for Tires and Pneumatic Tire - A rubber composition for tires according to the present technology comprises: a natural rubber, a diene-based blended rubber containing a solution-polymerized SBR and an emulsion-polymerized SBR, an aromatic modified terpene resin, a silica, and a carbon black. The solution-polymerized SBR contains a specific solution-polymerized SBR having a block containing an isoprene unit at one terminal thereof and a modified terminal for silica at the other terminal thereof. The styrene unit content in the emulsion-polymerized SBR is from 35 to 50 mass %. The content of the natural rubber and the total content of the solution-polymerized SBR and the emulsion-polymerized SBR in the diene-based blended rubber are specified, and the contents of aromatic modified terpene resin, the silica, and the carbon black relative to the content of the diene-based blended rubber are specified. | 2017-06-01 |
20170152375 | CROSS-LINKED RUBBER FOR LIQUEFIED GAS SEAL - A rubber obtained by cross-linking a highly saturated nitrile rubber composition has a carboxyl group-containing highly saturated nitrile rubber (A1) containing 15 to 60 wt % of α,β-ethylenically unsaturated nitrile monomer units and 1 to 60 wt % of α,β-ethylenically unsaturated dicarboxylic acid monoester monomer units and having an iodine value ≦120, a highly saturated nitrile rubber (A2) containing α,β-ethylenically unsaturated nitrile monomer units in 15 to 60 wt %, having a content of α,β-ethylenically unsaturated dicarboxylic acid monoester monomer units of 0.9 wt % or less, and an iodine value of 120 or less, a polyamide resin having a melting point ≧150° C., and a cross-linking agent. In the composition, a weight ratio of “(A1):(A2)” is 5:95 to 95:5 in range, a weight ratio of “total of (A1) and (A2):polyamide resin” is 95:5 to 50:50, and a storage elastic modulus of the cross-linked rubber at 150° C. is 5 MPa or more. | 2017-06-01 |
20170152376 | MULTIMODAL POLYETHYLENE COMPOSITION WITH HIGH PRESSURE RESISTANCE - The present invention relates to a multimodal polyethylene composition which can be manufactured into pipes showing improved pressure resistance comprising a high density multimodal ethylene polymer component (A) having a density of at least 930 kg/m | 2017-06-01 |
20170152377 | BREATHABLE FILMS AND ARTICLES INCORPORATING SAME - Breathable films formed from polyethylene are provided that can have desirable properties. In one aspect, a breathable film comprises a layer formed from a composition comprising a first composition, wherein the first composition comprises at least one ethylene-based polymer and wherein the first composition comprises a MWCDI value greater than 0.9, and a melt index ratio (I10/I2) that meets the following equation: I10/I2≧7.0−1.2×log(I2). | 2017-06-01 |
20170152378 | SLUSH MOLDING COMPOSITION - A thermoplastic polypropylene composition comprising polypropylene, a hydrogenated block copolymer, 3 to 6 wt % high density polyethylene, a processing oil, and greater than or equal to 3 wt % of a surface modifier comprising an ultra high molecular weight polydialkyl siloxane, an ultra-high molecular weight polydialkyl siloxane in combination with silica, a polyolefin siloxane or a combination thereof, wherein weight percent is based on the total weight of the composition. | 2017-06-01 |
20170152379 | PHOSPHOROUS-ACID MONOMER CONTAINING EMULSION POLYMER MODIFIED UREA-FORMALDEHYDE RESIN COMPOSITIONS FOR MAKING FIBERGLASS PRODUCTS - The present invention provides polymer modified aqueous urea formaldehyde resin (UF resin) binder compositions useful in making a treated glass mat, e.g., for roofing shingles, wherein the polymer modifier is an multistage aqueous emulsion acorn copolymer comprising one protuberant polymer stage containing phosphorous acid groups and one or more other polymer stage comprising an addition copolymer incompatible with the protuberant polymer stage, wherein the multistage aqueous emulsion copolymer has a measured Tg of from −60 to 25° C., or, preferably from 31 30 to 12° C. and, further wherein the weight ratio of the total of monomers used to make the one or more other polymer stage to the total amount of monomers used to make the protuberant polymer stage ranges from 3:1 to 50:1, or, preferably, from 3:1 to 30:1 or, more preferably, from 3:1 to 20:1, or, even more preferably, from 8:1 to 12:1. | 2017-06-01 |
20170152380 | CATALYST-LEAN, MICROCAPSULE-BASED SELF-HEALING MATERIALS VIA RING-OPENING METATHESIS POLYMERIZATION (ROMP) - A self-healing composite material includes a polymer matrix, microcapsules filled with a ring-opening metathesis-active monomer (e.g., norbornene, norbornene derivatives such as ethylidene norbornene, or cyclooctadiene), and polymeric particles comprised of a polymer that is soluble in the monomer with which the microcapsules are filled and having catalytic endgroups derived from an olefin metathesis catalyst, such as a Grubbs'-type catalyst. In some embodiments, the polymer having catalytic endgroups is synthesized via solution polymerization of a ring-opening metathesis-active monomer (e.g., norbornene, norbornene derivatives, or cyclooctadiene) in the presence of an olefin metathesis catalyst (e.g., Grubbs' 1st generation catalyst). The polymer having catalytic endgroups may then be processed via a grinding operation, for example, to prepare the small polymeric particles. In other embodiments, the polymeric particles are synthesized directly as microparticles (e.g., microspheres, granules, beads, etc.) utilizing an analogous suspension polymerization. | 2017-06-01 |
20170152381 | RUBBER COMPOSITION COMPRISING AN EPOXIDE ELASTOMER CROSS-LINKED BY A POLYCARBOXYLIC ACID - A rubber composition is based on at least one predominant elastomer comprising epoxide functional groups, silica as predominant reinforcing filler, an agent for covering the silica, and a system for crosslinking the elastomer comprising an imidazole and a polycarboxylic acid of general formula (I): | 2017-06-01 |
20170152382 | PROCESS FOR THE PREPARATION OF A SEMI-CRYSTALLINE SEMI-AROMATIC POLYAMIDE - The invention relates to a process for the preparation of a semi-crystalline semi-aromatic polyamide copolymer (Co-PA) having a melting temperature (Tm-Co-PA) of at least 300° C., comprising steps of (a) preparing a first semi-crystalline semi-aromatic polyamide (A), having a melting temperature (Tm-A) of at least 310° C.; and consisting of repeat units derived from 45-50 mol % terephthalic acid; 47.5-50 mol % of diamine; and 0-5 mol % of one or more other amine and/or acid group containing components; the mol % being relative to the total molar amount of said amine and/or acid group containing components; and wherein poly-amide (A) is prepared by a process comprising direct solid-state polymerization of a diamine-dicarboxylic acid salt of the terephthalis acid and the diamine; (b) providing a polyamide (B), being an amorphous polyamide having a glass transition temperature (Tg-B) below Tm-A, or a second semi-crystalline polyamide having a melting temperature (Tm-B) below Tm-A, or a combination of the amorphous polyamide and the second semi-crystalline polyamide; (c) heating and melt-mixing polyamide (A) and polyamide (B), thereby obtaining a miscible polymer melt with a temperature (T-melt) above Tm-A; and (d) cooling the melt to a temperature below the solidification temperature of the melt, thereby obtaining a solid semi-crystalline semi-aromatic polyamide copolymer. | 2017-06-01 |
20170152383 | Acrylic Composition with Olefin Block Copolymer - An acrylic composition includes a first component that accounts for 20 wt % to 40 wt % of the total weight of the acrylic composition and the first component includes an olefin block copolymer comprising hard segments and soft segments, of which the soft segments have from 9 mol % to less than 15 mol % of comonomer content. A second component of the acrylic composition accounts for 25 wt % to 70 wt % of the total weight of the acrylic composition and the second component includes at least one oil and at least one polyolefin. A third component of the acrylic composition accounts for 15 wt % to 65 wt % of the total weight of the acrylic composition and the third component includes acrylic particles having an average particle size from 0.5 μm to 30 μm and at least one inorganic filler. The acrylic particles account for at least 10 wt % of the total weight of the third component. | 2017-06-01 |
20170152384 | PROCESS FOR PREPARING A POLYMERIZED CASHEW NUT SHELL LIQUID AND ITS USE FOR THE PREPARATION OF A BITUMEN COMPOSITION - The invention relates to a method for the preparation of a polymerized CNSL composition, the method comprising subjecting a raw or technical CNSL to a heat treatment under reflux to obtain the polymerized CNSL composition, wherein the heat treatment is performed until the polymerized CNSL composition has a molecular weight M | 2017-06-01 |
20170152385 | METHOD FOR PREPARATION OF CARBON QUANTUM DOTS AND APPLICATION - The present invention provides carbon quantum dots, preparation method and uses thereof. The preparation method of the carbon quantum dots comprises the following steps: (1) preparing a dispersion of carbon based material; (2) mixing a solution of halogenated quinone with the dispersion of carbon based material and preparing a dispersion of carbon based-halogenated quinone composite material by halogenated quinone grafting method; (3) adding a solution of H | 2017-06-01 |
20170152386 | COPPER POWDER, AND COPPER PASTE, ELECTRICALLY CONDUCTIVE COATING MATERIAL AND ELECTRICALLY CONDUCTIVE SHEET EACH PRODUCED USING SAID COPPER POWDER - Provided is a copper powder in which the number of contact points between copper powder particles is increased to allow excellent electric conductivity to be achieved, and which can be used suitably in use applications including an electrically conductive paste and an electromagnetic wave shield. The copper powder according to the present invention has a dendritic shape composed of a main stem that is grown linearly and multiple branches that are branched from the main stem, wherein the main stem and the branches are composed of a flat-plate-like cupper particle having a cross section with an average thickness of 0.2 to 1.0 μm, and the average particle diameter (D50) of the copper powder is 5.0 to 30 μm. A copper paste having excellent electric conductivity can be produced by mixing the dendritic copper powder with a resin. | 2017-06-01 |
20170152387 | DUST REPELLANT AND ANTI-REFLECTIVE INORGANIC COATING AND METHOD FOR PREPARING THE SAME - The invention provides a dust repellant and anti-reflective inorganic coating and the method for preparing the coating. The dust repellant and anti-reflective inorganic coating includes nano-porous silica (SiO | 2017-06-01 |
20170152388 | Liquid Coating Compositions for Use in Methods for Forming a Superhydrophobic, Superoleophobic or Superamphiphobic Layer - The present invention provides for method for forming a superhydrophobic, superoleophobic or superamphiphobic layer and imparting said property on a surface, comprising the steps of a. preparing a liquid coating composition comprising a solvent and dispersed silicone nanoparticles, b. optionally priming the surface to form a primed surface on which a superhydrophobic, superoleophobic or superamphiphobic layer is to be formed, c. applying a layer of the liquid coating composition on the surface or primed surface on which the superhydrophobic, superoleophobic or superamphiphobic layer is to be formed, d. evaporating the solvent from the liquid coating composition to form a superhydrophobic, superoleophobic or superamphiphobic layer and impart said property on the surface or primed surface, wherein the dispersed silicone nanoparticles are formed by polymerization of at least one compound of formula I in an aprotic solvent comprising 5 to 500 ppm of water, | 2017-06-01 |